Paratek Pharmaceuticals is a leading independent biopharmaceutical company focused on developing transformative solutions for patients with infectious diseases and other challenging conditions. Our mission is to create positive stories for patients, physicians, and caregivers based on trust and integrity. We believe that with the right people, knowledge, and drugs, we can make a difference in patients' lives.

Our flagship product, NUZYRA®, is an FDA-approved tetracycline-class antibiotic designed to address a significant unmet need for adult patients with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible bacteria. This groundbreaking innovation has the potential to improve outcomes and provide relief to patients. At Paratek, we are driven by a dedicated and experienced team that is committed to saving lives.

We invite you to join us on our mission to develop novel life-saving products for life-threatening diseases and other public health threats. Paratek Pharmaceuticals - where positive outcomes and positive patient stories come to life